Orchard Therapeutics PLC (NASDAQ:ORTX)

Delayed Data
As of Oct 15
 +0.08 / +3.81%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Orchard Therapeutics PLC have a median target of 12.00, with a high estimate of 15.00 and a low estimate of 8.00. The median estimate represents a +450.46% increase from the last price of 2.18.

Chart unavailable

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Orchard Therapeutics PLC. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

Chart unavailable

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.76%
Growthannually 26.60%


Growthquarterly --
Growthannually 137.74%
Key to the earnings and sales forecast charts.